Be Vigilant When Starting Meds in Patients Taking Hep C Antivirals

July 2019

You'll face MANY potential drug interactions with hepatitis C antivirals (Epclusa, Mavyret, etc)...even if you didn't start these meds.

Interactions can lead to toxicity...or treatment failure. And this can be an expensive mistake...since antivirals cost up to $95,000/course.

Plus hep C meds may fly under the radar if you didn't prescribe them. Update the EHR with ALL meds...Rxs, OTCs, supplements, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote